IP Library Granted Patent US 8,945,932
Granted Patent B2
US 8,945,932 · App. 11/571,687 · Granted Feb 3, 2015

Methods and compositions for detecting and isolating phosphorylated molecules using hydrated metal oxides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,945,932
App. No.
11/571,687
Granted
Feb 3, 2015
Kind
B2
Abstract

The invention provides methods for detecting and isolating phosphomolecules using phosphoaffinity materials that comprise a hydrated metal oxide. In an embodiment, a method for detecting a phosphomolecule in a sample involves (a) contacting a sample with a phosphoaffinity material comprising a hydrated metal oxide, under conditions wherein a phosphomolecule is capable of binding to the phosphoaffinity material to form a phosphomolecule-phosphoaffinity material complex, and (b) detecting formation of a phosphomolecule-phosphoaffinity material complex, thereby detecting a phosphomolecule in the sample. In another embodiment, a method for isolating a phosphomolecule from a sample involves (a) contacting a sample with a phosphoaffinity material comprising a hydrated metal oxide, under conditions wherein a phosphomolecule is capable of binding to the phosphoaffinity material to form a phosphomolecule-phosphoaffinity material complex, wherein the hydrated metal oxide comprises yttrium, and (b) separating the phosphomolecule-phosphoaffinity material complex from the sample, thereby isolating the phosphomolecule from the sample.

Claims (36)

1. A method for detecting a phosphomacromolecule in a sample comprising:

(a) contacting the sample with a phosphoaffinity material comprising titanium dioxide, under conditions wherein the phosphomacromolecule is capable of binding to the phosphoaffinity material to form a phosphomacromolecule-phosphoaffinity material complex, wherein the phosphoaffinity material further comprises a support and wherein the support is selected from the group consisting of a particle, bead, gel, matrix, membrane, filter, fiber, sheet, mesh, frit, resin, sample vessel, column, pipette tip, slide channel, and MALDI-TOF plate; and

(b) detecting formation of the phosphomacromolecule-phosphoaffinity material complex, thereby detecting the phosphomacromolecule in the sample.

2. The method of claim 1 , wherein the detecting comprises measuring binding between the phosphomacromolecule and the phosphoaffinity material.

3. The method of claim 2 , wherein the measuring comprises measuring a physiochemical property of the phosphomacromolecule, the phosphoaffinity material, or both, wherein the physiochemical property is selected from the group consisting of absorbance, transmission, mass measurement, fluorescence intensity, fluorescence polarization, fluorescence resonance energy transfer, time-resolved fluorescence, resonance light scattering, surface-enhanced Raman scattering, electron paramagnetic resonance, refractive index absorbance, nuclear magnetic resonance, surface Plasmon resonance, refractive index changes, and combinations thereof.

4. The method of claim 1 , wherein the detecting comprises detecting the phosphoaffinity material portion of the phosphomacromolecule-phosphoaffinity material complex.

5. The method of claim 4 , wherein the titanium dioxide of the phosphoaffinity material portion is detected.

6. The method of claim 5 , wherein the titanium dioxide is detected using mass spectrometry.

7. The method of claim 6 , wherein the mass spectrometry is inductively-coupled plasma mass spectrometry.

8. The method of claim 1 , further comprising labeling the phosphoaffinity material with a detectable tag prior to detecting.

9. The method of claim 8 , wherein the detectable tag is a fluorescent moiety.

10. The method of claim 1 , wherein the titanium dioxide is labeled with a fluorescent moiety.

11. The method of claim 1 , wherein the detecting comprises detecting the phosphomacromolecule portion of the phosphomacromolecule-phosphoaffinity material complex.

12. The method of claim 11 , wherein the phosphomacromolecule portion is detected by inductively-coupled plasma mass spectrometry.

13. The method of claim 1 , wherein the detecting comprises detecting fluorescence resonance energy transfer.

14. The method of claim 13 , wherein fluorescence resonance energy transfer occurs between a fluorescent tag on the phosphomacromolecule and a fluorescent tag on the phosphoaffinity material.

15. The method of claim 1 , wherein the titanium dioxide is in particle form.

16. The method of claim 1 , wherein the support comprises an inorganic material.

17. The method of claim 1 , wherein the support is a particle.

18. The method of claim 17 , wherein the particle comprises a colloidal metal.

19. The method of claim 1 , wherein the support comprises an organic material.

20. The method of claim 1 , wherein the support is a sheet.

21. The method of claim 20 , wherein the sheet comprises cellulose.

22. The method of claim 1 , wherein the support comprises a detectable tag.

23. The method of claim 1 , wherein the phosphomacromolecule is a phosphorylated polypeptide.

24. The method of claim 1 , wherein the sample comprises a support.

25. The method of claim 1 , wherein the sample comprises a detectable tag.

26. The method of claim 1 , further comprising:

(c) isolating the phosphomacromolecule-phosphoaffinity material complex from the sample, thereby isolating the phosphomacromolecule from the sample.

27. The method of claim 26 , further comprising separating the phosphomacromolecule from the phosphomacromolecule-phosphoaffinity material complex.

28. The method of claim 1 , wherein the phosphomacromolecule is a phosphorylated polynucleotide.

29. The method of claim 1 , wherein the phosphomacromolecule is a phosphorylated lipid.

30. The method of claim 1 , wherein the phosphomacromolecule is a phosphorylated carbohydrate.

31. The method of claim 1 , wherein the support is a magnetic particle.

32. The method of claim 1 , wherein the support is a bead.

33. The method of claim 1 , wherein the support is a magnetic bead.

Assignments (3)
CHANGE OF NAME Recorded Mar 25, 2024
From: PERKINELMER HEALTH SCIENCES, INC.
To: REVVITY HEALTH SCIENCES, INC.
Reel/Frame 066881/0340 →
CHANGE OF NAME Recorded Oct 16, 2014
From: PERKINELMER LAS, INC.
To: PERKINELMER HEALTH SCIENCES, INC.
Reel/Frame 034014/0133 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2008
From: PATTON, WAYNE F.; MIKULSKIS, ALVYDAS; GOLENKO, EVA
To: PERKINELMER LAS, INC.
Reel/Frame 020939/0988 →